Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma

American Journal of Obstetrics and Gynecology

Volumn 158, Issue 2, 1988, Pages 399-402

  Patsner, Bruce ^a   Mann, William J ^a   Cohen, Heidi ^a   Loesch, Mary ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

CA 125; Endometrial cancer

Indexed keywords

CA 125 ANTIGEN;

ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERUM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; EPITOPES; FEMALE; HUMAN; MIDDLE AGE; NEOPLASM STAGING; PREOPERATIVE CARE; UTERINE NEOPLASMS;

EID: 0023869850     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(88)90163-9     Document Type: Article

References (10)

1. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types
2. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA-125) associated with human epithelial ovarian carcinoma
3. A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer
4. Elevation of serum CA-125 in carcinomas of the fallopian tube endometrium and endocervix
5. Primary radiation therapy for medically inoperable patients with endometrial carcinoma Stages I–II
6. Surgery for endometrial cancer
7. Adenocarcinoma of the body of the uterus
8. Reactivity of monoclonal antibody with human ovarian carcinoma
9. Elevation of serum CA-125 in carcinomas of the fallopian tube, endometrium, and endocervix
10. CA-125: a useful marker in endometrial carcinoma